Latest News in the pharma Industry

Policy & Regulation

FDA approves Zelboraf for Erdheim-Chester Disease

FDA approves Zelboraf for Erdheim-Chester Disease

6 Nov 2017

Zelboraf is the first FDA-approved treatment for Erdheim-Chester disease ECD, a rare blood disease.

Read more 
RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

RedHill Biopharma and IntelGenx submit NDA to FDA for Rizaport for migraines

2 Nov 2017

Rizaport is a proprietary oral thin-film formulation of rizatriptan for the treatment of acute migraines.

Read more 
FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

FDA approves AstraZeneca's Calquence for adult patients with mantle cell lymphoma

31 Oct 2017

Accelerated approval of Bruton tyrosine kinase inhibitor in MCL marks AstraZeneca's entry into the treatment of blood cancers.

Read more 
Mylan wins UK court ruling related to Copaxone 40 mg/mL patent

Mylan wins UK court ruling related to Copaxone 40 mg/mL patent

26 Oct 2017

Court finds all claims of Teva's patent relating to Copaxone invalid based on obviousness.

Read more 
New European Council of regulatory professionals set to shape and support the profession

New European Council of regulatory professionals set to shape and support the profession

18 Oct 2017

New European Council will support RAPS’ growing member base and volunteer network across Europe to ensure compliance with global regulations and to drive regulatory excellence

Read more 
FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen

FDA warns Pfizer company about cGMP violations associated with the manufacture of EpiPen

10 Sep 2017

Warning letter cites Meridian Medical Technologies' failure to thoroughly investigate multiple serious component and product failures of EpiPen products.

Read more 
Research reveals costly implementation is the biggest barrier to serialization compliance

Research reveals costly implementation is the biggest barrier to serialization compliance

7 Sep 2017

The time it takes to develop a solution has been gravely underestimated by a large part of the industry.

Read more 
Novo Nordisk settles US federal investigation of marketing practices

Novo Nordisk settles US federal investigation of marketing practices

7 Sep 2017

In connection with the $60 million settlement, the company has also resolved several private whistle-blower cases related to the government's investigation.

Read more 
Life-extending pancreatic cancer medicine recommended by NICE in final guidance

Life-extending pancreatic cancer medicine recommended by NICE in final guidance

6 Sep 2017

The pivotal Phase III study demonstrated that treatment with Abraxane in combination with gemcitabine can offer patients a median overall survival improvement of 1.8 months.

Read more 
Takeda disappointed as NICE issue second negative draft decision for ixazomib

Takeda disappointed as NICE issue second negative draft decision for ixazomib

5 Sep 2017

Company says it is determined to work collaboratively to find a solution.

Read more 
Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

Bayer submits BLA in the for BAY94-9027 – a long-acting factor VIII for the treatment of hemophilia A

3 Sep 2017

Pivotal studies with BAY94-9027 showed that bleed protection was achieved with extended dosing intervals.

Read more 
FDA approves Pfizer's Mylotarg for treatment of AML

FDA approves Pfizer's Mylotarg for treatment of AML

1 Sep 2017

Only approved antibody-drug conjugate for newly diagnosed and relapsed or refractory CD33-positive AML.

Read more